Hidden Bibliographic Details
| Varying Form of Title: | Pyridostigmine bromide
|
|---|
| Other authors / contributors: | United States. Department of Defense. Office of the Secretary of Defense.
National Defense Research Institute (U.S.)
Rand Corporation.
|
|---|
| ISBN: | 0585302359
9780585302355
0833026771
9780833026774
|
|---|
| Notes: | "The research was conducted in RAND's National Defense Research Institute, a federally funded research and development center supported by the OSD, the Joint Staff, the unified commands, and the defense agencies"--Page 2 of cover.
"MR-1018/2-OSD."
Includes bibliographical references (pages 303-385).
Print version record.
|
|---|
| Summary: | The United States and its allies in the Persian Gulf War (PGW) knew that Iraq had used nerve agents and chemical weapons in its previous conflicts and so took steps to protect their troops. Pyridostigmine bromide (PB) was distributed as a pretreatment that would enhance the effectiveness of postexposure treatments in the event that the nerve agent soman was used. This report examines the role that PB played in the ongoing chronic health problems documented in PGW veterans. After careful examination of the known effects of PB on the central and peripheral nervous systems, the author finds the evidence consistent with a possible role for PB as a contributor to the health complaints of some PGW veterans and calls for immediate attention in the form of additional investigation to clarify the role of PB.
|
|---|
| Other form: | Print version: Review of the scientific literature as it pertains to Gulf War illnesses. Santa Monica, CA : Rand, <1998-©2001> 0585302367
|
|---|
